BNCT is a cell-selective therapy that combines a boron drug with a neutron beam.
BNCT is a cell-selective therapy that combines a boron drug with a neutron beam.
Cancer cells are selectively destroyed with BNCT, thus reducing damage to normal cells.
BNCT can be applied to areas that have already been irradiated before.
BNCT requires only one or two sessions of radiation.
Treatment can be completed in a short period of time.
We use cookies to improve the user experience and gather anonymous visitor statistics. By using our website, you agree to the use of cookies.